153 results
8-K
EX-99.1
HROW
Harrow Inc
19 Mar 24
Harrow Announces Fourth Quarter and Year-End 2023 Financial Results
5:26pm
Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative
8-K
EX-99
HROW
Harrow Inc
15 Feb 24
Harrow Licenses Canadian Rights to Apotex For Five Branded Ophthalmic Pharmaceutical Products
4:15pm
access to an innovative branded line of ophthalmic products that complement our existing portfolio,” stated Allan Oberman, President and Chief … Executive Officer of Apotex. “This alliance expands Apotex’s product offering in Canada to include innovative patented pharmaceutical medicines, aligned
8-K
EX-99
HROW
Harrow Inc
29 Jan 24
Harrow Announces New Appointments to its Board of Directors
4:30pm
in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the U.S. market. Harrow helps U.S. eyecare
8-K
EX-99.1
xxydr375
13 Nov 23
Harrow Announces Third Quarter 2023 Financial Results
4:34pm
8-K
EX-99.1
56tc2g
29 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
EX-99.1
j95k zxhyw
9 Aug 23
Harrow Announces Second Quarter 2023 Financial Results
4:05pm
8-K
EX-99.2
wfmvwv8wzjd
9 Aug 23
Harrow Announces Second Quarter 2023 Financial Results
4:05pm
8-K
EX-99.1
5ihk fgq484aljsl
21 Jul 23
Harrow Prices $60 Million Public Offering of Common Stock
4:02pm
424B5
17avikxm1uwllj jgvv
19 Jul 23
Prospectus supplement for primary offering
5:19pm
424B5
ctj8jc6rlwksd62
18 Jul 23
Prospectus supplement for primary offering
5:03pm
8-K
EX-99.4
wwpt1 779c9vwie
18 Jul 23
Harrow Provides Select Preliminary Second Quarter 2023 Financial Guidance
4:59pm
8-K
EX-99.2
a5cvv6f4abtrahv2h0l
18 Jul 23
Harrow Provides Select Preliminary Second Quarter 2023 Financial Guidance
4:59pm
8-K
EX-99.1
ywj7fcsa6ujz92
18 Jul 23
Harrow Provides Select Preliminary Second Quarter 2023 Financial Guidance
4:59pm
8-K
EX-99.5
mgis33tl
18 Jul 23
Harrow Provides Select Preliminary Second Quarter 2023 Financial Guidance
4:59pm